Your Article Summary
See Latest ArticlesProtective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia–reperfusion
Cardiovascular Research, 06/30/09
Hofmann U et al. - Pharmacological S1P receptor agonists have distinct effects on ischaemia–reperfusion injury. Their efficacy when applied during reperfusion makes them potential candidates for pharmaceutical postconditioning therapy after cardiac ischaemia.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (from the TYCOON [Two-Year ClOpidOgrel Need] Study)
The American Journal of Cardiology, 11/05/09
Choosing among renin-angiotensin system blockers for the management of hypertension: from pharmacology to clinical efficacy
Current Medical Research and Opinion, 11/23/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09
Today in Myocardium/Pericardium...keeping you current
Receive free subspecialty "5-minute updates" via email
Vitamin D and cardiovascular disease
Current Atherosclerosis Reports, 11/12/09
Rosuvastatin along the cardiovascular continuum: from JUPITER to AURORA
Expert Review of Cardiovascular Therapy , 11/16/09
Cardiac troponin-I as a screening tool for myocarditis in children hospitalized for viral infection
Acta Pediatrica, 11/16/09